These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2143883)

  • 21. Monoclonal antibody OPD4 detects neoplastic T cells but does not distinguish between CD4 and CD8 neoplastic T cells in paraffin tissue sections.
    Chadburn A; Husain S; Knowles DM
    Hum Pathol; 1992 Aug; 23(8):940-7. PubMed ID: 1353748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Koning N; Bö L; Hoek RM; Huitinga I
    Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic phenotype of Langerhans cell histiocytosis: an immunohistochemical study demonstrating the value of LN-2, LN-3, and vimentin.
    Azumi N; Sheibani K; Swartz WG; Stroup RM; Rappaport H
    Hum Pathol; 1988 Dec; 19(12):1376-82. PubMed ID: 2973428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions.
    Itoyama Y; Sternberger NH; Webster HD; Quarles RH; Cohen SR; Richardson EP
    Ann Neurol; 1980 Feb; 7(2):167-77. PubMed ID: 6154440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discrimination between immunoaccessory and phagocytic monocytes/macrophages of the skin in paraffin-embedded tissue by the monoclonal antibody Ki-M1P.
    Boehncke WH; Dörhage KW; Harms D; Radzun HJ; Hauschild A; Sterry W
    Br J Dermatol; 1993 Aug; 129(2):124-30. PubMed ID: 7654569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galectin-3/MAC-2 in experimental allergic encephalomyelitis.
    Reichert F; Rotshenker S
    Exp Neurol; 1999 Dec; 160(2):508-14. PubMed ID: 10619568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
    Wolswijk G
    Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions.
    Werner K; Bitsch A; Bunkowski S; Hemmerlein B; Brück W
    Glia; 2002 Oct; 40(1):121-9. PubMed ID: 12237849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the immunopathology of multiple sclerosis lesions.
    Traugott U
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):37-45. PubMed ID: 1285383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination.
    Bajramović JJ; Plomp AC; Goes Av; Koevoets C; Newcombe J; Cuzner ML; van Noort JM
    J Immunol; 2000 Apr; 164(8):4359-66. PubMed ID: 10754336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques.
    Prineas JW; Kwon EE; Cho ES; Sharer LR
    Ann N Y Acad Sci; 1984; 436():11-32. PubMed ID: 6598010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions.
    De Groot CJ; Ruuls SR; Theeuwes JW; Dijkstra CD; Van der Valk P
    J Neuropathol Exp Neurol; 1997 Jan; 56(1):10-20. PubMed ID: 8990125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoring immune suppression in the multiple sclerosis brain.
    Koning N; Uitdehaag BM; Huitinga I; Hoek RM
    Prog Neurobiol; 2009 Dec; 89(4):359-68. PubMed ID: 19800386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination.
    Lee NJ; Ha SK; Sati P; Absinta M; Luciano NJ; Lefeuvre JA; Schindler MK; Leibovitch EC; Ryu JK; Petersen MA; Silva AC; Jacobson S; Akassoglou K; Reich DS
    Brain; 2018 Jun; 141(6):1637-1649. PubMed ID: 29688408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain.
    Tanaka R; Iwasaki Y; Koprowski H
    Am J Pathol; 1975 Dec; 81(3):467-78. PubMed ID: 1211421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemistry of germ cell and trophoblastic neoplasms.
    Niehans GA; Manivel JC; Copland GT; Scheithauer BW; Wick MR
    Cancer; 1988 Sep; 62(6):1113-23. PubMed ID: 2457424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis.
    Peferoen LA; Vogel DY; Ummenthum K; Breur M; Heijnen PD; Gerritsen WH; Peferoen-Baert RM; van der Valk P; Dijkstra CD; Amor S
    J Neuropathol Exp Neurol; 2015 Jan; 74(1):48-63. PubMed ID: 25470347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive oil-spot-like lesion in multiple sclerosis.
    Petrescu A
    Acta Neuropathol Suppl; 1981; 7():182-4. PubMed ID: 6939231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunohistochemical heterogeneity of atheroma macrophages: comparison with lymphoid tissues suggests that recently blood-derived macrophages can be distinguished from longer-resident cells.
    Poston RN; Hussain IF
    J Histochem Cytochem; 1993 Oct; 41(10):1503-12. PubMed ID: 7504008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
    Prineas JW; Kwon EE; Goldenberg PZ; Ilyas AA; Quarles RH; Benjamins JA; Sprinkle TJ
    Lab Invest; 1989 Nov; 61(5):489-503. PubMed ID: 2811298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.